Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 895 | N/A | N/A |
| Receivables | 18 | N/A | N/A |
| TOTAL | $913 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 7 | N/A | N/A |
| Investments And Advances | 35 | 0 | 0 |
| TOTAL | $42 | $N/A | $N/A |
| Total Assets | $955 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 37 | 0 | 0 |
| TOTAL | $37 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $37 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -1,577 | N/A | N/A |
| TOTAL | $918 | $N/A | $N/A |
| Total Liabilities And Equity | $955 | $0 | $0 |